Previous 10 |
home / stock / ipot:cc / ipot:cc news
VANCOUVER, British Columbia, May 19, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) a multi-faceted organization with a natural health medicine division in Canada and holdings in Israel, is pleased to announ...
VANCOUVER, British Columbia, April 15, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) is pleased to announce that further to its acquisition of Praesidio Health Inc. as a natural health medicine division, th...
VANCOUVER, British Columbia, April 13, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) is pleased to announce that, further to the Company’s news releases dated February 23, 2022 and March 28, 2022, it...
VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) is pleased to announce that, further to the Company’s news release dated February 23, 2022, it has entered into a ...
News, Short Squeeze, Breakout and More Instantly...
Isracann Biosciences Inc. Company Name:
IPOT:CC Stock Symbol:
CNQC Market:
Toronto, Ontario--(Newsfile Corp. - Le 6 avril/April 2023) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or...
IIROC Trading Halt - IPOT Canada NewsWire VANCOUVER, BC , April 6, 2023 /CNW/ - The following issues have been halted by IIROC: Company: Isracann Biosciences Inc. CSE Symbol: IPOT All Issues: Yes Reason: Cease Trade Order Halt Time (ET): 9:29 AM...
VANCOUVER, British Columbia, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) announces that further to its news release dated September 29, 2022 (the “ Default Announcement ”), the Comp...